Kaplan–Meier analysis in this cohort of patients also validated our previous study [12], showing that SRF expression is associated with survival from diagnosis with prostate cancer (Figure 5D) and with time to developing resistance to androgen deprivation therapy (Figure 5E). This evidence concerns the gene SRF and prostate carcinoma.